Photo by: J. Scott Applewhite House Oversight Committee Chairman Rep. Darrell Issa, California Republican, is concerned that a new Food and Drug Administration rule that would allow generic drug companies to change warning labels without approval has no health benefits, and was designed to placate special interest groups and could increase lawsuits. (Associated Press)
Trump was the subject of an apparent assassination attempt at his Florida golf club, the FBI says Shares
North Korea gives a glimpse of a secretive uranium-enrichment facility as Kim pushes for more nukes Shares
Teen charged with killing 4 at Georgia high school had been focus of earlier tips about threats Shares